Stonvex publishes market data and research only. Not investment advice. Not a registered investment advisor. Read disclaimer.

PACB

Live52w low +42.2%

Core line items from PACB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.

Entity: Pacific Biosciences of California, Inc.·Source: SEC EDGAR companyfacts

Metric	Annual 2018 2018-12-31	Annual 2017 2017-12-31	Annual 2016 2016-12-31
Revenue	$78.63M	$93.47M	$90.71M
Operating Income	$-100.99M	$-89.78M	$-71.24M
Net Income	$-102.56M	$-92.19M	$-74.38M
EPS (Diluted)	$-0.76	Not available	Not available
Total Assets	$170.28M	$144.08M	$137.88M
Total Liabilities	$56.21M	$57.98M	$53.22M
Cash & Equivalents	$18.84M	$16.51M	$16.77M
Free Cash Flow OCF − CapEx	$-68.28M	$-77.95M	$-76.14M
Shares Outstanding	150.24M	116.28M	92.68M

Financial data is sourced from public SEC filings where available. Some metrics may be unavailable without premium market data.

Core line items from PACB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.

52w low +42.2%

Entity: Pacific Biosciences of California, Inc.·Source: SEC EDGAR companyfacts

Metric	Annual 2018 2018-12-31	Annual 2017 2017-12-31	Annual 2016 2016-12-31
Revenue	$78.63M	$93.47M	$90.71M
Operating Income	$-100.99M	$-89.78M	$-71.24M
Net Income	$-102.56M	$-92.19M	$-74.38M
EPS (Diluted)	$-0.76	Not available	Not available
Total Assets	$170.28M	$144.08M	$137.88M
Total Liabilities	$56.21M	$57.98M	$53.22M
Cash & Equivalents	$18.84M	$16.51M	$16.77M
Free Cash Flow OCF − CapEx	$-68.28M	$-77.95M	$-76.14M
Shares Outstanding	150.24M	116.28M	92.68M

Financial data is sourced from public SEC filings where available. Some metrics may be unavailable without premium market data.